ARCUTIS BIOTHERAPEUTICS, INC. Depreciation
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) reported Depreciation of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-25
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for the quarter ending 2025-03-31 was $153.00K, a 10.00% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for the quarter ending 2024-12-31 was $105.00K, a 53.74% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for the quarter ending 2024-09-30 was $161.00K, a 19.50% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for the quarter ending 2024-06-30 was $164.00K, a 17.17% decline year-over-year.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for fiscal 2025 was $700.00K, a 16.67% increase from fiscal 2024.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for fiscal 2024 was $600.00K, a 25.00% decline from fiscal 2023.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for fiscal 2023 was $800.00K, a 28.62% increase from fiscal 2022.
- ARCUTIS BIOTHERAPEUTICS, INC. depreciation for fiscal 2022 was $622.00K, a 37.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $700.00K 10-K · filed 2026-02-25 | ||||
| 2025-03-31 | $153.00K 10-Q · filed 2025-05-06 | $258.00K derived: sum of 2 quarters · filed 2026-02-25 | $419.00K derived: sum of 3 quarters · filed 2026-02-25 | $583.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $266.00K derived: sum of 2 quarters · filed 2026-02-25 | $430.00K derived: sum of 3 quarters · filed 2026-02-25 | $600.00K 10-K · filed 2026-02-25 | $640.00K 10-K · filed 2025-02-25 |
| 2024-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $325.00K derived: sum of 2 quarters · filed 2024-11-06 | $495.00K 10-Q · filed 2024-11-06 | $722.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $334.00K 10-Q · filed 2024-08-14 | $561.00K derived: sum of 3 quarters · filed 2026-02-25 | $761.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $170.00K 10-Q · filed 2025-05-06 | $397.00K derived: sum of 2 quarters · filed 2026-02-25 | $597.00K derived: sum of 3 quarters · filed 2026-02-25 | $795.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $427.00K derived: sum of 2 quarters · filed 2026-02-25 | $625.00K derived: sum of 3 quarters · filed 2026-02-25 | $800.00K 10-K · filed 2026-02-25 | $771.00K 10-K · filed 2024-02-27 |
| 2023-09-30 | $200.00K 10-Q · filed 2023-11-03 | $398.00K derived: sum of 2 quarters · filed 2023-11-03 | $573.00K 10-Q · filed 2024-11-06 | $733.00K derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $198.00K 10-Q · filed 2023-08-08 | $373.00K 10-Q · filed 2024-08-14 | $533.00K derived: sum of 3 quarters · filed 2025-02-25 | $690.00K derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $175.00K 10-Q · filed 2024-05-14 | $335.00K derived: sum of 2 quarters · filed 2025-02-25 | $492.00K derived: sum of 3 quarters · filed 2025-02-25 | $647.00K derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $317.00K derived: sum of 2 quarters · filed 2025-02-25 | $472.00K derived: sum of 3 quarters · filed 2025-02-25 | $622.00K 10-K · filed 2025-02-25 | |
| 2022-09-30 | $157.00K 10-Q · filed 2023-11-03 | $312.00K derived: sum of 2 quarters · filed 2023-11-03 | $462.00K 10-Q · filed 2023-11-03 | $598.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $155.00K 10-Q · filed 2023-08-08 | $305.00K 10-Q · filed 2023-08-08 | $441.00K derived: sum of 3 quarters · filed 2024-02-27 | $557.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $150.00K 10-Q · filed 2023-05-09 | $286.00K derived: sum of 2 quarters · filed 2024-02-27 | $402.00K derived: sum of 3 quarters · filed 2024-02-27 | $506.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $252.00K derived: sum of 2 quarters · filed 2024-02-27 | $356.00K derived: sum of 3 quarters · filed 2024-02-27 | $454.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $116.00K 10-Q · filed 2022-11-08 | $220.00K derived: sum of 2 quarters · filed 2022-11-08 | $318.00K 10-Q · filed 2022-11-08 | $353.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $104.00K 10-Q · filed 2022-08-04 | $202.00K 10-Q · filed 2022-08-04 | $237.00K derived: sum of 3 quarters · filed 2023-02-28 | $267.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $98.00K 10-Q · filed 2022-05-05 | $133.00K derived: sum of 2 quarters · filed 2023-02-28 | $163.00K derived: sum of 3 quarters · filed 2023-02-28 | $193.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $65.00K derived: sum of 2 quarters · filed 2023-02-28 | $95.00K derived: sum of 3 quarters · filed 2023-02-28 | $122.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $30.00K 10-Q · filed 2021-11-04 | $60.00K derived: sum of 2 quarters · filed 2021-11-04 | $87.00K 10-Q · filed 2021-11-04 | $111.00K derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-05 | $57.00K 10-Q · filed 2021-08-05 | $81.00K derived: sum of 3 quarters · filed 2022-02-22 | $100.00K derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-06 | $51.00K derived: sum of 2 quarters · filed 2022-02-22 | $70.00K derived: sum of 3 quarters · filed 2022-02-22 | $90.00K derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $43.00K derived: sum of 2 quarters · filed 2022-02-22 | $63.00K derived: sum of 3 quarters · filed 2022-02-22 | $68.00K 10-K · filed 2022-02-22 | |
| 2019-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $39.00K derived: sum of 2 quarters · filed 2020-11-05 | $44.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $25.00K 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-12 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |